to enjoy learning and progressing in cardiometabolic practice

11th ACC 2025: HOST-BR Trial

12th ACC 2025: RIVAWAR Trial

6th ACC 2025: FRESH-UP Study

14th ACC 2025: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y

15th ACC 2025: DapaTAVI Trial

9th ACC 2025: ALIGN-AR Trial

10th ACC 2025: FAIR-HF2 Trial

16th ACC 2025: MI and Cardiovascular Risks Associated with Cannabis Use

8th ACC 2025: BHF PROTECT-TAVI Trial

2nd ACC 2025: ADVANCE-HTN Trial

1st ACC 2025: SMART-CHOICE 3 Trial

Antithrombotic Therapy in CCS

Antithrombotic Therapy in ACS

Antithrombotic Therapy in VTE

Antithrombotic Therapy in AF

POCUS Basic Echocardiography

17th AHA 2024: VANISH2 Trial

14th AHA 2024: PHARM-HF A&F Trial

15th AHA 2024: TOPSPIN Trial

Preventive Cardiology

Preventive Cardiology

16th AHA 2024: ALPACAR-360 Trial

13th AHA 2024: ENDEAVOR Trial

10th AHA 2024: BROOKLYN Trial

6th AHA 2024: ATTR Cardiomyopathy

5th AHA 2024: REALIZE-K Trial

Case Discussion 123: Borderline QT Interval

4th AHA 2024: AI image-recognition for heart images

3rd AHA 2024: BRAIN-AF Trial

Case Discussion 120: VTE prophylaxis

Case Discussion 119: CAC Score

21st H&H Academy Session

21st H&H Academy Session

Case Discussion 118: Omalizumab in CVD

1st AHA 2024: OASIS 9 Trial

Online Grand Round: Approach to NSTE-ACS